Cargando…

Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures

INTRODUCTION: Esophageal involvement in patients with systemic sclerosis (SSc) is common, but tissue-specific pathological mechanisms are poorly understood. There are no animal scleroderma esophagus models and esophageal smooth muscle cells dedifferentiate in culture prohibiting in vitro studies. Es...

Descripción completa

Detalles Bibliográficos
Autores principales: Taroni, Jaclyn N., Martyanov, Viktor, Huang, Chiang-Ching, Mahoney, J. Matthew, Hirano, Ikuo, Shetuni, Brandon, Yang, Guang-Yu, Brenner, Darren, Jung, Barbara, Wood, Tammara A., Bhattacharyya, Swati, Almagor, Orit, Lee, Jungwha, Sirajuddin, Arlene, Varga, John, Chang, Rowland W., Whitfield, Michael L., Hinchcliff, Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518531/
https://www.ncbi.nlm.nih.gov/pubmed/26220546
http://dx.doi.org/10.1186/s13075-015-0695-1
_version_ 1782383368979087360
author Taroni, Jaclyn N.
Martyanov, Viktor
Huang, Chiang-Ching
Mahoney, J. Matthew
Hirano, Ikuo
Shetuni, Brandon
Yang, Guang-Yu
Brenner, Darren
Jung, Barbara
Wood, Tammara A.
Bhattacharyya, Swati
Almagor, Orit
Lee, Jungwha
Sirajuddin, Arlene
Varga, John
Chang, Rowland W.
Whitfield, Michael L.
Hinchcliff, Monique
author_facet Taroni, Jaclyn N.
Martyanov, Viktor
Huang, Chiang-Ching
Mahoney, J. Matthew
Hirano, Ikuo
Shetuni, Brandon
Yang, Guang-Yu
Brenner, Darren
Jung, Barbara
Wood, Tammara A.
Bhattacharyya, Swati
Almagor, Orit
Lee, Jungwha
Sirajuddin, Arlene
Varga, John
Chang, Rowland W.
Whitfield, Michael L.
Hinchcliff, Monique
author_sort Taroni, Jaclyn N.
collection PubMed
description INTRODUCTION: Esophageal involvement in patients with systemic sclerosis (SSc) is common, but tissue-specific pathological mechanisms are poorly understood. There are no animal scleroderma esophagus models and esophageal smooth muscle cells dedifferentiate in culture prohibiting in vitro studies. Esophageal fibrosis is thought to disrupt smooth muscle function and lead to esophageal dilatation, but autopsy studies demonstrate esophageal smooth muscle atrophy and the absence of fibrosis in the majority of SSc cases. Herein, we perform a detailed characterization of SSc esophageal histopathology and molecular signatures at the level of gene expression. METHODS: Esophageal biopsies were prospectively obtained during esophagogastroduodenoscopy in 16 consecutive SSc patients and 7 subjects without SSc. Upper and lower esophageal biopsies were evaluated for histopathology and gene expression. RESULTS: Individual patient’s upper and lower esophageal biopsies showed nearly identical patterns of gene expression. Similar to skin, inflammatory and proliferative gene expression signatures were identified suggesting that molecular subsets are a universal feature of SSc end-target organ pathology. The inflammatory signature was present in biopsies without high numbers of infiltrating lymphocytes. Molecular classification of esophageal biopsies was independent of SSc skin subtype, serum autoantibodies and esophagitis. CONCLUSIONS: Proliferative and inflammatory molecular gene expression subsets in tissues from patients with SSc may be a conserved, reproducible component of SSc pathogenesis. The inflammatory signature is observed in biopsies that lack large inflammatory infiltrates suggesting that immune activation is a major driver of SSc esophageal pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0695-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4518531
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45185312015-07-30 Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures Taroni, Jaclyn N. Martyanov, Viktor Huang, Chiang-Ching Mahoney, J. Matthew Hirano, Ikuo Shetuni, Brandon Yang, Guang-Yu Brenner, Darren Jung, Barbara Wood, Tammara A. Bhattacharyya, Swati Almagor, Orit Lee, Jungwha Sirajuddin, Arlene Varga, John Chang, Rowland W. Whitfield, Michael L. Hinchcliff, Monique Arthritis Res Ther Research Article INTRODUCTION: Esophageal involvement in patients with systemic sclerosis (SSc) is common, but tissue-specific pathological mechanisms are poorly understood. There are no animal scleroderma esophagus models and esophageal smooth muscle cells dedifferentiate in culture prohibiting in vitro studies. Esophageal fibrosis is thought to disrupt smooth muscle function and lead to esophageal dilatation, but autopsy studies demonstrate esophageal smooth muscle atrophy and the absence of fibrosis in the majority of SSc cases. Herein, we perform a detailed characterization of SSc esophageal histopathology and molecular signatures at the level of gene expression. METHODS: Esophageal biopsies were prospectively obtained during esophagogastroduodenoscopy in 16 consecutive SSc patients and 7 subjects without SSc. Upper and lower esophageal biopsies were evaluated for histopathology and gene expression. RESULTS: Individual patient’s upper and lower esophageal biopsies showed nearly identical patterns of gene expression. Similar to skin, inflammatory and proliferative gene expression signatures were identified suggesting that molecular subsets are a universal feature of SSc end-target organ pathology. The inflammatory signature was present in biopsies without high numbers of infiltrating lymphocytes. Molecular classification of esophageal biopsies was independent of SSc skin subtype, serum autoantibodies and esophagitis. CONCLUSIONS: Proliferative and inflammatory molecular gene expression subsets in tissues from patients with SSc may be a conserved, reproducible component of SSc pathogenesis. The inflammatory signature is observed in biopsies that lack large inflammatory infiltrates suggesting that immune activation is a major driver of SSc esophageal pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0695-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-29 2015 /pmc/articles/PMC4518531/ /pubmed/26220546 http://dx.doi.org/10.1186/s13075-015-0695-1 Text en © Taroni et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Taroni, Jaclyn N.
Martyanov, Viktor
Huang, Chiang-Ching
Mahoney, J. Matthew
Hirano, Ikuo
Shetuni, Brandon
Yang, Guang-Yu
Brenner, Darren
Jung, Barbara
Wood, Tammara A.
Bhattacharyya, Swati
Almagor, Orit
Lee, Jungwha
Sirajuddin, Arlene
Varga, John
Chang, Rowland W.
Whitfield, Michael L.
Hinchcliff, Monique
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
title Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
title_full Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
title_fullStr Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
title_full_unstemmed Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
title_short Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
title_sort molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518531/
https://www.ncbi.nlm.nih.gov/pubmed/26220546
http://dx.doi.org/10.1186/s13075-015-0695-1
work_keys_str_mv AT taronijaclynn molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT martyanovviktor molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT huangchiangching molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT mahoneyjmatthew molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT hiranoikuo molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT shetunibrandon molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT yangguangyu molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT brennerdarren molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT jungbarbara molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT woodtammaraa molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT bhattacharyyaswati molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT almagororit molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT leejungwha molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT sirajuddinarlene molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT vargajohn molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT changrowlandw molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT whitfieldmichaell molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures
AT hinchcliffmonique molecularcharacterizationofsystemicsclerosisesophagealpathologyidentifiesinflammatoryandproliferativesignatures